Sudden Cardiac Death in Dilated Cardiomyopathy – Therapeutic Options

@article{Grimm2002SuddenCD,
  title={Sudden Cardiac Death in Dilated Cardiomyopathy – Therapeutic Options},
  author={Wolfram Grimm and Bernhard Maisch},
  journal={Herz},
  year={2002},
  volume={27},
  pages={750-759}
}
Despite routine use of angiotensin-converting enzyme (ACE) inhibitors, β-blockers and spironolactone in patients with heart failure due to dilated cardiomyopathy (DCM), these patients still have a considerable annual mortality rate of 5–10%. Sudden unexpected death accounts for up to 50% of all deaths and is most often due to rapid ventricular tachycardia or ventricular fibrillation and less often due to bradyarrhythmias or asystole. Therapeutic Options: The use of β-blockers in patients with… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 47 references

Coronary artery bypass graft patch trial.

Pacing and clinical electrophysiology : PACE • 1993
View 7 Excerpts
Highly Influenced

CAT Investigators. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy

D Bänsch, M Antz, S Boczor
Circulation • 2002
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…